NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

Various factors seem to have contributed to 23andMe’s decline. Its kits are a one-time product, so there is little prospect ...

HIGHLIGHTS Recent exploration by Novo at the Clone prospect included detailed structural, lithological and regolith mapping, ...